Pharmacy Benefit Consulting
  • Services
    • Total Oversight
    • PBM Selection
    • Data analysis
    • Audit Rx/Claims
  • About
  • Articles & Resources
  • Contact us
Select Page

Invokana Pricing slashed via The Mark Cuban Cost Plus Drug Company

Apr 1, 2023 | Newsletter

Invokana Pricing slashed via The Mark Cuban Cost Plus Drug Company April 2023 The Mark Cuban Cost Plus Drug Company has announced that they have entered into a contract with JanssenUS, a subsidiary of Johnson and Johnson, to distribute Invokana, an important...

Novo Nordisk and Sanofi to cut Insulin prices, following moves by Eli Lilly

Mar 1, 2023 | Newsletter

Novo Nordisk and Sanofi to cut Insulin prices, following moves by Eli Lilly March 2023Novo Nordisk to cut U.S. list prices for several insulin products by up to 75% next year. Sanofi announced that it will cut prices by 78%. Effective January 1st, 2024. Generally...

Senators introduced bills to reform PBMs and create new FTC probe

Feb 1, 2023 | Newsletter

Senators introduced bills to reform PBMs and create new FTC probe February 2023 U.S. Senator Cantwell (D-Wash) recently re-introduced the Pharmacy Benefit Manager Transparency Act of 2022 which was previously co-sponsored by herself and Senator Grassley (R-Iowa). The...

Next Entries »